United States · FDA National Drug Code directory
Cerdelga
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58468-0220_e71b0b39-5a29-4e38-8500-55b6d1f48543
- Product NDC
- 58468-0220
- Form
- CAPSULE
- Composition / generic term
- eliglustat
- Labeler
- Genzyme Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20140903
- Source listing expiry
- 20261231
Source-listed ingredients
- ELIGLUSTAT — 84 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BLISTER PACK in 1 CARTON (58468-0220-1) / 14 CAPSULE in 1 BLISTER PACK · 58468-0220-1
- 1 BLISTER PACK in 1 CARTON (58468-0220-2) / 14 CAPSULE in 1 BLISTER PACK · 58468-0220-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →